FindTrial
Sign In

Adverse events of endoscopic resection for gastric tumors

Adverse events after endoscopic submucosal dissection for gastric neoplasms: a population-based study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0011604
Enrollment
80000
Registered
2026-02-11
Start date
2024-04-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Kyung Hee University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who underwent upper gastrointestinal endoscopic submucosal dissection (ESD) (procedure code: QZ933) with a primary diagnosis of benign neoplasm of the stomach (D13.1), carcinoma in situ of the stomach (D00.2), or gastric cancer (C16).

Exclusion criteria

Exclusion criteria: 1. Patients with a history of esophageal or gastric surgery 2. Patients with neoplasms of uncertain or unknown behavior of the stomach (D37) 3. Procedures performed in primary clinics or outpatient settings 4. Synchronous gastric lesions

Design outcomes

Primary

MeasureTime frame
Bleeding;Perforation;Pneumonia;Intensive care unit admission—

Secondary

MeasureTime frame
Risk factors associated with each outcome—

Countries

Korea, Republic of

Contacts

Public ContactJung-Wook Kim

Kyung Hee University Hospital

iloveact@hanmail.net+82-2-958-8200

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Mar 14, 2026